Rajesh Devraj is a venture partner at Atlas Venture and president and CEO of Rectify Pharmaceuticals. He previously co-founded and led science at Disarm Therapeutics, was chief scientific officer of Padlock Therapeutics, and held leadership roles at Euclises, Deciphera, Jubilant and Pfizer.
Rajesh Devraj is a venture partner at Atlas Venture and president and CEO of Rectify Pharmaceuticals. He previously co-founded and led science at Disarm Therapeutics, was chief scientific officer of Padlock Therapeutics, and held leadership roles at Euclises, Deciphera, Jubilant and Pfizer.
Career
Venture Partner at Atlas Venture until PresentRPPresident and Chief Executive Officer at Rectify Pharmaceuticals until Present
DTCo-founder and Chief Scientific Officer at Disarm Therapeutics until 2020
PTChief Scientific Officer at Padlock Therapeutics until 2016